Physician profile
Daniel Matthew Hoopes
NPI 1255505582
$10,056.54
in general payments reported to CMS, 2019-2025
21 companies · $2,258 in 2025
The $2,258 reported for 2025 was more than what a typical Foot and Ankle Surgery provider received nationally (typical 2025 total: $1,200).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $279 · 2020: $264 · 2021: $149 · 2022: $2,521 · 2023: $1,054 · 2024: $3,532 · 2025: $2,258.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,575 · Consulting Fee: $1,860 · Food and Beverage: $1,409.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,574.52 |
| Consulting Fee | $1,860.00 |
| Food and Beverage | $1,409.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $4,024.82 | 2019-2025 | Mako, Prostep, Infinity Adaptis |
| Conformis, INC. | $2,471.98 | 2022 | |
| Medical Device Business Services, INC. | $1,860.00 | 2025 | |
| Paragon 28, INC. | $772.30 | 2024 | Additive Orthopedics, Portfolio, Apex 3d |
| Innovation Technologies INC | $230.73 | 2020-2021 | |
| Depuy Synthes Sales INC. | $134.34 | 2019-2024 | Dynaforce, Unium, Na |
| Pacira Therapeutics, INC. | $79.56 | 2019-2020 | |
| Orthofix Medical, INC. | $71.86 | 2023-2025 | Physio-Stim |
| Smith+Nephew, INC. | $67.86 | 2021-2025 | Panta 2, Evos Mini, Evos |
| Molnlycke Health Care US, LLC | $54.95 | 2019 | |
| Zimmer Biomet Holdings, INC. | $48.88 | 2022 | |
| Bioventus LLC | $45.42 | 2025 | Exogen Ultrasound Bone Healing System |
| Amgen INC. | $31.35 | 2019 | |
| Sanofi-Aventis U.S. LLC | $26.53 | 2019 | |
| Medtronic, INC. | $24.16 | 2025 | Inceptiv |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vericel Corporation | $23.08 | 2019 | |
| Merck Sharp & Dohme LLC | $22.60 | 2025 | Verquvo |
| Solventum Corporation | $18.09 | 2025 | Activ.A.C., Prevena |
| Vertex Pharmaceuticals Incorporated | $17.89 | 2025 | |
| Kci USA, INC. | $15.46 | 2020 | |
| Boston Scientific Corporation | $14.68 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Hoopes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.